Warning Letters | FDA
FDA issued a warning letter to BlephEx, LLC for medical device adulteration/misbranding, but this does not directly impact dietary supplement businesses. However, it signals increased FDA enforcement vigilance.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Dietary supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: N/A. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA posted a warning letter for a medical device, not dietary supplements. No direct regulatory change for supplement businesses.
Who it affects
Dietary supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
No immediate action required. Continue monitoring FDA warning letters for supplement-specific enforcement.
Deadline
N/A
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- Filing of Color Additive Petition From the International Association of Color Manufacturers; Request To Amend the Color Additive Regulations To Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene Dichloride
- After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
- Texas Updates Food Labeling Law: 44 Ingredients Require Warning Labels - CIRS Group
- FDA Educational Materials Outline New Dietary Ingredient Notification Process for Supplements - Quality Assurance & Food Safety
- Draft Guidance on NDIN Master Files for Dietary Supplements - fda.gov